These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10803931)

  • 1. Poor clinical outcome of patients with Hodgkin's disease and elevated interleukin-10 serum levels. Clinical significance of interleukin-10 serum levels for Hodgkin's disease.
    Bohlen H; Kessler M; Sextro M; Diehl V; Tesch H
    Ann Hematol; 2000 Mar; 79(3):110-3. PubMed ID: 10803931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 levels are often elevated in serum of adults with Hodgkin's disease and are associated with inferior failure-free survival.
    Sarris AH; Kliche KO; Pethambaram P; Preti A; Tucker S; Jackow C; Messina O; Pugh W; Hagemeister FB; McLaughlin P; Rodriguez MA; Romaguera J; Fritsche H; Witzig T; Duvic M; Andreeff M; Cabanillas F
    Ann Oncol; 1999 Apr; 10(4):433-40. PubMed ID: 10370786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of elevated serum levels of interleukin 6 in patients with untreated Hodgkin's disease.
    Seymour JF; Talpaz M; Hagemeister FB; Cabanillas F; Kurzrock R
    Am J Med; 1997 Jan; 102(1):21-8. PubMed ID: 9209197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum interleukin 6 levels are elevated in lymphoma patients and correlate with survival in advanced Hodgkin's disease and with B symptoms.
    Kurzrock R; Redman J; Cabanillas F; Jones D; Rothberg J; Talpaz M
    Cancer Res; 1993 May; 53(9):2118-22. PubMed ID: 8481913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cytokine levels correlate with clinical parameters in Hodgkin's disease.
    Gorschlüter M; Bohlen H; Hasenclever D; Diehl V; Tesch H
    Ann Oncol; 1995 May; 6(5):477-82. PubMed ID: 7545429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy.
    Visco C; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Medeiros LJ; Notti P; Rassidakis GZ; Peethambaram P; Wilder R; Witzig T; Gianni M; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
    Leuk Lymphoma; 2004 Oct; 45(10):2085-92. PubMed ID: 15370254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of circulating interleukin-6 in patients with Hodgkin's disease.
    Gause A; Scholz R; Klein S; Jung W; Diehl V; Tesch H; Hasenclever D; Pfreundschuh M
    Hematol Oncol; 1991; 9(6):307-13. PubMed ID: 1748397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated pretreatment serum levels of Il-10 are associated with a poor prognosis in Hodgkin's disease, the milan cancer institute experience.
    Viviani S; Notti P; Bonfante V; Verderio P; Valagussa P; Bonadonna G
    Med Oncol; 2000 Feb; 17(1):59-63. PubMed ID: 10713662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of circulating cytokines in patients with untreated Hodgkin's disease.
    Gause A; Keymis S; Scholz R; Schobert I; Jung W; Diehl V; Pohl C; Pfreundschuh M
    Lymphokine Cytokine Res; 1992 Apr; 11(2):109-13. PubMed ID: 1581417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-treatment serum levels of interleukin-10, interleukin-12 and their ratio predict response to therapy and probability of event-free and overall survival in childhood soft tissue sarcomas, Hodgkin's lymphomas and acute lymphoblastic leukemias.
    Bien E; Balcerska A; Adamkiewicz-Drozynska E; Rapala M; Krawczyk M; Stepinski J
    Clin Biochem; 2009 Jul; 42(10-11):1144-57. PubMed ID: 19376105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological markers may add to prediction of outcome achieved by the International Prognostic Score in Hodgkin's disease.
    Axdorph U; Sjöberg J; Grimfors G; Landgren O; Porwit-MacDonald A; Björkholm M
    Ann Oncol; 2000 Nov; 11(11):1405-11. PubMed ID: 11142480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
    Albitar M; Vose JM; Johnson MM; Do KA; Day A; Jilani I; Kantarjian H; Keating M; O'Brien SM; Verstovsek S; Armitage JO; Giles FJ
    Leuk Res; 2007 Feb; 31(2):139-45. PubMed ID: 16545870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma.
    Vassilakopoulos TP; Nadali G; Angelopoulou MK; Siakantaris MP; Dimopoulou MN; Kontopidou FN; Rassidakis GZ; Doussis-Anagnostopoulou IA; Hatzioannou M; Vaiopoulos G; Kittas C; Sarris AH; Pizzolo G; Pangalis GA
    Haematologica; 2001 Mar; 86(3):274-81. PubMed ID: 11255274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum levels of interleukin-9 correlate to negative prognostic factors in Hodgkin's lymphoma.
    Fischer M; Bijman M; Molin D; Cormont F; Uyttenhove C; van Snick J; Sundström C; Enblad G; Nilsson G
    Leukemia; 2003 Dec; 17(12):2513-6. PubMed ID: 14562126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High pretreatment interleukin-10 is an independent predictor of poor failure-free survival in patients with Hodgkin's lymphoma.
    Salgami EV; Efstathiou SP; Vlachakis V; Sekara EV; Syrigos KN; Roussou PP
    Haematologia (Budap); 2002; 32(4):377-87. PubMed ID: 12803112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum concentrations of cytokines in patients with Hodgkin's disease.
    Blay JY; Farcet JP; Lavaud A; Radoux D; Chouaïb S
    Eur J Cancer; 1994; 30A(3):321-4. PubMed ID: 8204352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
    Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
    Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnostic and prognostic value of serum cytokines (soluble CD30, soluble interleukin-2 receptor, interleukin-10 and interleukin-6) in Hodgkin's disease and lymphosarcomas].
    Iaguzhinskaia OE; Lazarev IE; Nikitin EA; Samoĭlova RS; Loginova IV; Gemdzhan EG; Novikov VA; Mamiliaeva ZKh; Pivnik AV
    Ter Arkh; 2001; 73(4):45-51. PubMed ID: 11494447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-7, interleukin-8, soluble TNF receptor, and p53 protein levels are elevated in the serum of patients with Hodgkin's disease.
    Trümper L; Jung W; Dahl G; Diehl V; Gause A; Pfreundschuh M
    Ann Oncol; 1994; 5 Suppl 1():93-6. PubMed ID: 8172827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 in non-Hodgkin's lymphoma.
    Cortes J; Kurzrock R
    Leuk Lymphoma; 1997 Jul; 26(3-4):251-9. PubMed ID: 9322887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.